Next, we compared the levels of tumor-infiltrating B cells, T cells and their subsets, and NK cells expressing PD-1, TIM-3, LAG-3, TIGIT, and ICOS between patients with advanced and early stage CRC. This evidence concerns the gene PDCD1 and colorectal carcinoma.